SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Swiss Pharma and Chemicals Slip in Technology and Clinical Trials

A yearly Global Industry Competitiveness Index showed Switzerland’s pharmaceutical and chemicals industries slipping behind in technology and clinical trials. Switzerland ranked third overall among the most competitive locations.

NOTRO
SquawkNews Desk

Related stories

Lyell Immunopharma Announces $80M Private Placement Lyell Immunopharma says the private placement will advance Ronde-Cel toward a planned BLA submission. M impact | EQUITY | Nov 04, 2026, 02:09 PM UTC Spartan Delta Reports Q3 Results, Raises 2026 Capital Plan and Sets 2027 Guidance Third-quarter Adjusted Funds Flow was $109.5 million, up 117% year over year, on production of 53,448 BOE/d and record 46% liquids weighting. Spartan raised its 2026 capital progra M impact | EQUITY | Nov 04, 2026, 02:02 PM UTC European session market picture: S&P 500 +1.17%, Nasdaq 100 +0.35%; EUR/USD +0.63%, WTI -2.92%, LLOY leads volume European session market picture. US index futures: S and P futures is up 1.17 percent, Nasdaq futures is up 0.35 percent, Dow futures is up 2.22 percent and Russell futures is up 1 M impact | EQUITY | Nov 04, 2026, 02:02 PM UTC Dolphin to Host Q3 2026 Earnings Call on November 10 Dolphin said it will host its third-quarter 2026 earnings conference call on November 10, 2026. M impact | EQUITY | Nov 04, 2026, 02:01 PM UTC Immunome Reports 53% ORR in 19 B-NHL Patients At the June 26, 2026 interim cutoff, 10 of 19 response-evaluable B-NHL patients had an overall response, including five complete and five partial responses. In the 11-patient DLBCL M impact | EQUITY | Nov 04, 2026, 02:01 PM UTC SM Energy Reports Third-Quarter Revenue of $2.17 Billion Third-quarter net income was $93 million and diluted EPS was $0.39, compared with $155 million and $1.35 a year earlier. Production averaged 433.1 MBOE per day, down 2% sequentiall M impact | EQUITY | Nov 04, 2026, 02:01 PM UTC